MARX Biotech Co., Ltd. (TPEX:7731)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Retail - Drugs	635.85M	618.23M	289.93M	110.64M
Total	635.85M	618.23M	289.93M	110.64M

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Taiwan	632.33M	615.54M	284.62M	104.45M
China	967.00K	1.03M	3.30M	4.39M
Singapore and Malaysia	800.00K	1.66M	2.00M	1.80M
United State	1.75M	-	-	-
Total	635.85M	618.23M	289.93M	110.64M

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 7, 2026

Data Sources Report a data error